Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Updates on metastatic bladder cancer from ASCO GU 2019

Prof Arlene Siefker-Radtke - MD Anderson Cancer Center, Houston, USA

Updates on metastatic bladder cancer from ASCO GU 2019 ( Prof Arlene Siefker-Radtke - MD Anderson Cancer Center, Houston, USA )

KEYNOTE-426: Pembrolizumab and axitinib vs sunitinib in advanced renal cell...

Prof Brian Rini - Cleveland Clinic, Cleveland, USA

KEYNOTE-426: Pembrolizumab and axitinib vs sunitinib in advanced renal cell carcinoma ( Prof Brian Rini - Cleveland Clinic, Cleveland, USA )

ASCO GU 2019 renal highlights

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA

ASCO GU 2019 renal highlights ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )

ARCHES trial: Androgen deprivation therapy with enzalutamide or placebo in mHSPC

Prof Andrew Armstrong - Duke Cancer Institute, Durham, USA

ARCHES trial: Androgen deprivation therapy with enzalutamide or placebo in mHSPC ( Prof Andrew Armstrong - Duke Cancer Institute, Durham, USA )

Latest from Tivo-3: Tivozanib for refractory advanced renal cell carcinoma

Prof Brian Rini - Cleveland Clinic, Cleveland, USA

$Latest from Tivo-3: Tivozanib for refractory advanced renal cell carcinoma ( Prof Brian Rini - Cleveland Clinic, Cleveland, USA )$

Sacituzumab govitecan in patients with previously treated metastatic urothelial...

Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA

Sacituzumab govitecan in patients with previously treated metastatic urothelial cancer ( Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA )

Whole genome and transcriptome analysis of metastatic adrenocortical carcinoma

Dr Jean-Michel Lavoie - BC Cancer, Vancouver, Canada

Whole genome and transcriptome analysis of metastatic adrenocortical carcinoma ( Dr Jean-Michel Lavoie - BC Cancer, Vancouver, Canada )

Updates from KEYNOTE 57: Pembrolizumab for patients with bladder cancer

Dr Arjun Balar - NYU Langone Health, New York City, USA

Updates from KEYNOTE 57: Pembrolizumab for patients with bladder cancer ( Dr Arjun Balar - NYU Langone Health, New York City, USA )

CHEIRON study: Docetaxel plus enzalutamide versus docetaxel as first-line...

Dr Orazio Caffo - Santa Chiara Hospital, Trento, Italy

CHEIRON study: Docetaxel plus enzalutamide versus docetaxel as first-line chemotherapy for patients with mCRPC ( Dr Orazio Caffo - Santa Chiara Hospital, Trento, Italy )

Treating metastatic prostate cancer in geriatric patients

Dr Shabbir Alibhai - Princess Margaret Cancer Center, Toronto, Canada

Treating metastatic prostate cancer in geriatric patients ( Dr Shabbir Alibhai - Princess Margaret Cancer Center, Toronto, Canada )

Improving the management of senior adults with prostate cancer

Prof Amit Bahl, Prof Nicolas Mottet, Prof Jean-Pierre Droz and Henriette Breunis

Improving the management of senior adults with prostate cancer ( Prof Amit Bahl, Prof Nicolas Mottet, Prof Jean-Pierre Droz and Henriette Breunis )

TRITON2: Evaluation of rucaparib in patients with metastatic castration...

Dr Josep Piulats - IDIBELL, Barcelona, Spain

TRITON2: Evaluation of rucaparib in patients with metastatic castration-resistant prostate cancer ( Dr Josep Piulats - IDIBELL, Barcelona, Spain )

More from ecancer